Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsSøren Lund Kristensen, John J.V. McMurray, David Preiss et al.|The Lancet Diabetes & Endocrinology|2019Cited by 1.6k
Risk Models for Prediction of Implantable Cardioverter-Defibrillator BenefitSøren Lund Kristensen, Jens Jakob Thune, Wayne C. Levy et al.|JACC Heart Failure|2019Cited by 43
Adverse effects of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysisAndrea Pozzi, Giacomo Corrado, Carlo Cirelli et al.|Heart Failure Reviews|2023Cited by 8